Skip to Content

7.00% p.a. JB Callable Barrier Reverse Convertible (60%) on Basilea Pharmaceutica AG

  • Valor 138282716
  • ISIN CH1382827165
  • Symbol SAQNJB
  • SVSP Category Yield enhancement
  • SVSP Type Barrier Reverse Convertibles
  • SVSP Code 1230

Bid

%

Volume:

Ask

%

Volume:

Price

as of:

Key values

Performance since issue 0.85%
max. return 2.85%
max. return p.a. 4.82%
Distance to strike (%) 24.29%
Distance to barrier +54.57%
Delta BSLN=0.015

Basic values

multiple Underlyings No
days to maturity 218
Summary Risk Indicator (SRI)*
1 2 3 4 5 6 7

*All statements without guarantee.

ESG

JB ESG Category Traditional investment
SFDR Alignment (JB View) No
EU Taxonomy Aligned No
% of EU Taxonomy Alignment 0.00%

Performance

Daily high (bid) 100.90
Daily low (bid) 100.85
52 Week high (bid) 101.45
52 Week low (bid) 96.95
Alltime high (bid) 101.45
Alltime low (bid) 96.95
Worst performing underlying Basilea Pharmaceutica Ltd
Performance of the underlying since issue 32.08%

Agenda

Initial fixing date 19/11/2024
Issue date 26/11/2024
Next coupon payment 26/08/2025
Maturity date 19/02/2026
Callability Yes

Key values at issue

Issuer Bank Julius Baer & Co. Ltd., Guernsey
Underlying Basilea Pharmaceutica Ltd
Issue price 100.00
Currency CHF
Listing Yes
COSI No
Coupon p.a. 7.00%
Strike 39.75
Barrier (%) 60.00%
Barrier observation continuous
Quanto No
Trigger Barrier 60.00%
Trigger Step-Down No

documents

PRIIPs KID

Terms

Termsheet

Description

Payment Scenario Barrier Reverse Convertibles
market expectation
characteristics
Payment Scenario Barrier Reverse Convertibles
  • Underlying moving sideways or slightly rising
  • Falling volatility
  • Underlying will not breach barrierduring product lifetime
  • Should the barrier never be breached, the nominal plus coupon is paid at redemption
  • Due to the barrier, the probability of maximum redemption is higher; the coupon, however, is smaller than for a Reverse Convertible
  • If the barrier is breached the product changes into a Reverse Convertible
  • The coupon is paid regardless of the underlying development
  • Reduced risk compared to a direct investment into the underlying
  • With higher risk levels, multiple underlyings (“Worst-of”) allow for higher coupons or lower barriers
  • Limited profit opportunity(cap)
>Please refer to SSPA website for more information

Performance

Underlying

Basilea Pharmaceutica Ltd

  • Ticker SymbolBSLN SW
  • Valor1143244
  • ISINCH0011432447

53.20 CHF

UnderlyingValorISINPriceStrikeBarrier absoluteRatio
Basilea Pharmaceutica Ltd 1143244 CH0011432447 +0.00% 39.75 23.85
Back to top

Julius Baer Structured Products Legal Disclaimer Switzerland

Please read the following terms of use and legal information carefully.

Legal regulations Switzerland
  1. In General
    1. Agreement

      By using the website www.juliusbaer.com and any of its pages (hereafter the "Site"), you confirm that you have reviewed, understand and agree to the following important legal information and terms of use (the "Terms").If you do not agree to the Terms, please exit the Site immediately.

The Terms are subject to change at any time without notice and access to, and use of the Site may be restricted or terminated at any time.

Access to and use of the Site as well as the Terms are governed by Swiss law. The place of jurisdiction is Zurich.

    1. No offer, no advice

      The information, products, data, services, tools and documents contained or described on this site (the "Content") are for information purposes only and constitutes neither an advertisement or recommendation nor an offer or solicitation to buy or sell investment instruments, to effect any transaction or to enter into any legal relations.

      The financial products mentioned on this site are not suitable for all investors. The information contained on this site represents no financial, legal, tax and/or any other recommendation whatsoever. Investment decisions or other decisions should not be made exclusively on the basis of this document. Prior to making any investment decisions, we recommend that you seek a thorough review as well as advice from a qualified specialist.

    2. No warranty

      Julius Baer provides no warranty and makes no representations of any kind whatsoever regarding: (1) the currency, accuracy or completeness of the content; (2) the results to be obtained by any user of the Site; or (3) any third party content accessible on or through the Site.

      Any data, including but not limited to financial market data, quotes, notices, research or other financial information accessible through this Site, have been obtained from carefully selected sources believed to be reliable. All such information is provided "as is" to the user without express or implied warranties of any kind, including warranties of quality, originality, non-infringement of intellectual property or fitness for any particular purpose. The fact that a user accesses the Site does not make him a client of Julius Baer. Any expressions of opinion, estimates and projections on the Site are those of the authors at the date of writing. They do not necessarily reflect the view of Julius Baer and are subject to change at any time without prior warning. Julius Baer and its contractual partners may discontinue, or make changes in, the information, data and documents, and the products or services described herein, at any time without prior notice. Any information marked with a date is published as of this date only and no obligation or responsibility is undertaken to update or amend any such information.

    3. No liability

      TO THE MAXIMUM EXTENT PERMITTED BY CURRENT LAWS AND/OR REGULATIONS, JULIUS BAER, INCLUDING ITS DIRECTORS, AGENTS, EMPLOYEES, SUB-CONTRACTORS AND ITS SALES PARTNERS DISCLAIM ANY AND ALL LIABILITY FOR LOSSES OR DAMAGES OF ANY KIND WHATSOEVER ARISING DIRECTLY OR INDIRECTLYAS A RESULT OF (1) THE CONTENT, ACCURACY, COMPLETENESS OR OTHERWISE OF THE CONTENT OR ANY LINKS OR THIRD PARTY CONTENT; (2) ANY ERRORS IN OR OMISSIONS FROM THE SITE; (3) USE OF OR ACCESS TO THE SITE; (4) ANY INABILITY TO ACCESS OR USE THE WEBSITE FOR ANY REASON. TO THE FULL EXTENT PERMITTED BY CURRENT LAWS AND/OR REGULATIONS, JULIUS BAER SHALL NOT BE LIABLE FOR ANY (1) LOSS OF PROFITS OR REVENUE OR SAVINGS OR OTHER ECONOMIC LOSS, (2) LOSS OF BUSINESS OR GOODWILL, (3) LOSS OF OR DAMAGE TO DATA, (4) INCIDENTAL OR SPECIAL LOSS, (5) WASTED OR LOST MANAGEMENT TIME, OR (6) INDIRECT OR CONSEQUENTIAL LOSS ARISING FROM USE OF OR ACCESS TO THE SITE, EVEN IF ADVISED OF THE POSSIBILITY OF ANY SUCH LOSS OR DAMAGE OR IF SUCH LOSS OR DAMAGE WAS FORESEEABLE.

    4. Proprietary information

      Unless accompanied by an explicit statement to the contrary, all content on this Site is protected by copyright, database rights, or other intellectual property rights, and is the property of Julius Baer. Nothing on the Site is designed to grant any license or right to use any image, text, trademark or logo. No act of downloading or otherwise copying from the Site will transfer any legal entitlement to any software or material on the Site to you. Julius Baer reserves all intellectual property rights (such as copyright, design and trademark rights) to all material on the Site, and will enforce such rights to the full extent of applicable law. Any reproduction, re-publication or distribution of site content requires the express written authorization of Julius Baer as well as the explicit source data.

    5. Proprietary information

      Unless accompanied by an explicit statement to the contrary, all content on this Site is protected by copyright, database rights, or other intellectual property rights, and is the property of Julius Baer. Nothing on the Site is designed to grant any license or right to use any image, text, trademark or logo. No act of downloading or otherwise copying from the Site will transfer any legal entitlement to any software or material on the Site to you. Julius Baer reserves all intellectual property rights (such as copyright, design and trademark rights) to all material on the Site, and will enforce such rights to the full extent of applicable law. Any reproduction, re-publication or distribution of site content requires the express written authorization of Julius Baer as well as the explicit source data.

    6. Material interests

      Julius Baer and/or its board of directors, executive management and employees may have or have had interests or positions or traded or acted as market makers in securities referred to on the Site. Furthermore, such entities or persons may have or have had a relationship with or may provide or have provided corporate finance or other services to or serve or have served as directors of companies referred to on the Site.

    7. Performance

      The past is not an indication of the future performance of an investment. The value of investments may be subject to fluctuations and investors may not get back the amount invested. Changes in rates of foreign exchange may also cause the value of investments to go up or down.

  2. Structured Products

    Access to data under the section "Structured Products" is designated exclusively for visitors to the site with domicile in Switzerland. Access to the section "Structured Products" is prohibited for visitors to the site from other countries, and these users must exit the website.

    Data under the section "Structured Products" serve as information only and constitute neither a solicitation nor invitation of an offer. Any buy or sell offer is provided only with the complete documentation, which particularly points out the risks associated with these financial products and can be obtained from Bank Julius Baer & Co. Ltd. (tel. +41 (0) 58 888 81 81, Structured Products Team, Hohlstrasse 604/606, 8010 Zurich). Investors are urged to read this documentation carefully since they provide the conditions under which an investor can invest in the product. Please note that conversations conducted on our trading telephone can be recorded. Structured products do not represent participation in a collective investment and are thus not subject to supervisory authority by the Swiss Financial Market Supervisory Authority (FINMA). Investors are therefore not protected under the Swiss Federal Act on Collective Capital Investments (CCIA) and are thus exposed to issuer risk.

Show full textLess options
Decline and return to juliusbaer.com